1Mannucci RA, Ognibene A, Crenasco F, et al. Effect of metformin on glucagon-like peptide 1 (GLP- 1 )and leptin in obesse non-diabetic subiects. Diabetes Care 2001; 24:489-494.
2Hinke SA, Kuhn-Wache K, Hoffmann T, et al. Metformin effec.ts of dipep.tiylpeptidase IV degradation of glucagons-like peptide- 1. Biochemical and Biophysical Research communications2002 ; 292 : 1302- 1308.
3Fenerici M, Herbal M, Perego L, et al. High glucose causes apoptosis in cultured human pancreatic islets of langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes 2001 ; 50 (6) : 1290-301.
4Gorogawa S, Kajimoto Y, Umayahara H, et al. Probucol preserves pancreatic beta-cell function throuth reduction of oxidative stress in type 2 diabetes. Diabetes Res Clin Pract 2002; 57(1):1-10.
5Kaneto H, Kajimoto Y, Miyagawa T, et al. Benificial effects of antioxidant in diabetes: possible protection of pancreatic beta-cell against toxicity. Diabetes 1999;38(12):2398-406.
6Wang Q, Brubaker PL. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice. Diabetilogia 2002:45 : 1263- 1273.
7Chiasson JL, Josse RG, Gomis R, et al. Acarbose prevention of Type 2 diabetes: STOP-NIDDM random trail. Lancet 2002 ; 359 : 2072- 2077.
8DeLeon MJ, Chandurkar V, Albert SG, Mooradian AD.Glucagon-like petide-1 response to acarose in elderly type 2 diabetes subjects. Diabetes Res and Clin Pract 2002;56 : 101 - 106.
9Leahy JL, Weir GC. Beta cell dysfunction in hyperglycemia rat models:Recovery of glucose induced insulin secretion with lowering of the ambient glucose level. Diabetologia 1991;34:640 - 647.
10Serradas P, Bailbe - D, Blondel O, et al. Abnormal B cell function in rats with non - insulin - dependent- diabetes induced by neonatal streptozotocin : effect of in vivo insulin, phlorizin., or vandata treatments, Panceras 1991 ;6 : 54 - 62.
